From: Differences in discontinuation of statin treatment in women and men with advanced cancer disease
Reasons for termination of statin treatment | Total (n = 54) n (%) | Men (n = 25) n (%) | Women (n = 29) n (%) |
---|---|---|---|
Risk for harm greater than benefit | 11 (20) | 8 (32) | 3 (10) |
Short lifetime expectancy | 10 (19) | 4 (16) | 6 (21) |
Cachexia | 3 (6) | 1 (4) | 2 (7) |
Fatigue | 1 (2) | 0 (0) | 1 (3) |
Dysphagia | 1 (2) | 0 (0) | 1 (3) |
Not specified | 28 (52) | 12 (48) | 16 (55) |